Besides lung cancer, TCGA data suggest that SBF2-AS1 is overexpressed in various kinds of cancer, including renal clear cell carcinoma, head and neck squamous cell carcinoma, and liver cancer. This evidence concerns the gene SBF2 and head and neck squamous cell carcinoma.